Supernus Pharmaceuticals Stock Is an Institutional Favorite

A gain of approximately 80% over the past year for Supernus Pharmaceuticals, Inc. (SUPN) stock likely could not have happened without strong institutional accumulation of its shares. When looking for the strongest candidates for long-term upside, it can be helpful to look where big investors are likely wagering on upside. Betting on leading stocks with growing earningsand sales, great technicals, and bullish institutional activity can be a great recipe for long-term investors.

Read More